Keyphrases
Antibody-drug Conjugate
100%
Radiation-inducible
100%
TIP1
100%
Radiosensitization
100%
Non-small Cell Lung Cancer Cells
33%
Tumor Growth
33%
Cancer Cells
33%
Non-small Cell Lung Cancer (NSCLC)
33%
Radiotherapy
33%
Endocytosis
33%
Clinical Trials
16%
Recombinant
16%
Pharmacokinetics
16%
Cell Surface
16%
High Affinity
16%
In Cancer
16%
Dissociation
16%
Lung Cancer Patients
16%
Tumor Model
16%
A549
16%
Specific Binding
16%
A549 Cells
16%
Promising Strategies
16%
Therapeutic Efficacy
16%
Improved Survival
16%
Cytotoxicity
16%
Colony Formation
16%
Cancer-specific
16%
Viable Cells
16%
Surviving Fraction
16%
Growth Studies
16%
Cytotoxic Drugs
16%
Long Circulation Time
16%
H1299
16%
H1299 Cells
16%
Drug-to-antibody Ratio
16%
Cancer Specificity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Antibody Drug Conjugate
100%
Non Small Cell Lung Cancer
66%
Tumor Growth
33%
Combination Therapy
16%
Clinical Trial
16%
Lung Cancer
16%
Tumor Model
16%
Antibody Design
16%
Pharmacokinetics
16%
Cytotoxicity
16%
Cytotoxic Agent
16%
Immunology and Microbiology
Antibody Drug Conjugate
100%
Cancer Cell
80%
Endocytosis
40%
Cell Surface
20%
Internalization
20%
Cytotoxicity
20%
Colony Formation
20%
Pharmacokinetics
20%
Antibody Design
20%